Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet E Olson

Showing results (131-140 of 258) with videos related to

Pageof 26
Sort By:
Blood Cancer Journal|November 6, 2024
Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)Aswin Sekar, Rosalie Griffin, Sameer A Parikh, et al.
NPJ Breast Cancer|November 29, 2025
Plasma assay of methylated DNA markers detects recurrent metastatic breast cancerKarthik V Giridhar, Jason P Sinnwell, Seth W Slettedahl, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 8, 2024
Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studiesLynette M Smith, Douglas W Mahoney, William R Bamlet, et al.
Blood Cancer Journal|November 6, 2025
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)Nicholas J Boddicker, Tait D Shanafelt, Sameer A Parikh, et al.
The Journal of Clinical Endocrinology and Metabolism|January 8, 2023
Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk PatientsSuzette J Bielinski, Licy L Yanes Cardozo, Paul Y Takahashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Inherited determinants of ovarian cancer survivalEllen L Goode, Matthew J Maurer, Thomas A Sellers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2018
<i>CDKN2A</i> Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority PopulationsRobert R McWilliams, Eric D Wieben, Kari G Chaffee, et al.
Leukemia|July 21, 2021
Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African AmericansGeffen Kleinstern, J Brice Weinberg, Sameer A Parikh, et al.
Human Molecular Genetics|April 11, 2013
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelMine S Cicek, Devin C Koestler, Brooke L Fridley, et al.
Journal of the National Cancer Institute|March 7, 2015
The contributions of breast density and common genetic variation to breast cancer riskCeline M Vachon, V Shane Pankratz, Christopher G Scott, et al.
Pageof 26

Showing results (131-140 of 258) with videos related to

Sort By:
Pageof 26
Blood Cancer Journal|November 6, 2024
Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)Aswin Sekar, Rosalie Griffin, Sameer A Parikh, et al.
NPJ Breast Cancer|November 29, 2025
Plasma assay of methylated DNA markers detects recurrent metastatic breast cancerKarthik V Giridhar, Jason P Sinnwell, Seth W Slettedahl, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 8, 2024
Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studiesLynette M Smith, Douglas W Mahoney, William R Bamlet, et al.
Blood Cancer Journal|November 6, 2025
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)Nicholas J Boddicker, Tait D Shanafelt, Sameer A Parikh, et al.
The Journal of Clinical Endocrinology and Metabolism|January 8, 2023
Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk PatientsSuzette J Bielinski, Licy L Yanes Cardozo, Paul Y Takahashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Inherited determinants of ovarian cancer survivalEllen L Goode, Matthew J Maurer, Thomas A Sellers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2018
<i>CDKN2A</i> Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority PopulationsRobert R McWilliams, Eric D Wieben, Kari G Chaffee, et al.
Leukemia|July 21, 2021
Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African AmericansGeffen Kleinstern, J Brice Weinberg, Sameer A Parikh, et al.
Human Molecular Genetics|April 11, 2013
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelMine S Cicek, Devin C Koestler, Brooke L Fridley, et al.
Journal of the National Cancer Institute|March 7, 2015
The contributions of breast density and common genetic variation to breast cancer riskCeline M Vachon, V Shane Pankratz, Christopher G Scott, et al.
Pageof 26